Mitigating the Immunogenicity of AAV-Mediated Gene Therapy with an Immunosuppressive Phosphoserine-Containing Zwitterionic Peptide.

Yuan, Zhefan; Li, Bowen; Gu, Wenchao; Luozhong, Sijin; Li, Ruoxin; Jiang, Shaoyi

Yuan, Zhefan; Li, Bowen; Gu, Wenchao; Luozhong, Sijin; Li, Ruoxin; Jiang, Shaoyi.

Afiliación

Yuan Z; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
Li B; Department of Chemical Engineering, University of Washington, Seattle, Washington 98195, United States.
Gu W; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
Luozhong S; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
Li R; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
Jiang S; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.

J Am Chem Soc ; 144(44): 20507-20513, 2022 11 09.

Article en En | MEDLINE | ID: mdl-36301739

Asunto(s)

Dependovirus; Terapia Genética; Animales; Ratones; Fosfoserina; Dependovirus/genética; Vectores Genéticos; Ratones Noqueados; Péptidos/genética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Dependovirus Límite: Animals Idioma: En Revista: J Am Chem Soc Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google